Jan 27 (Reuters) - Immutep Ltd (IMM) :
- IMMUTEP - ANNOUNCES ADVANCEMENT OF PHASE II TRIAL FOR EFTILAGIMOD ALPHA IN COVID- 19 PATIENTS
News: IMM Immutep Announces Advancement Of Phase 2 Trial For Eftilagimod Alpha
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $534.9M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3373 | 46.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 2712 | 1 |
View Market Depth
| Last trade - 16.16pm 03/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable